Cytokinetics (CYTK) Receivables (2016 - 2026)
Cytokinetics' Receivables came in at $24.43 million for Q2 2026, up 190.5% from $8.41 million a year earlier and up 257.9% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Receivables (2016 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics' Receivables was $17.76 million, up 6.7% from FY2024.
- Receivables carries a five-year compound annual growth rate of 32.1% (FY2020 to FY2025).
- Going back by year, Receivables was $16.65 million in FY2024, $1.28 million in FY2023 (+772.8%), $147,000 in FY2022 (-99.7%) and $51.82 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Receivables since Q4 2021.
- Year-over-year, Receivables has increased for four consecutive quarters, with growth averaging 188.1% over the last six quarters.
- The fastest year-over-year change in Receivables over five years came in Q4 2023 (growth of 772.8%), and the weakest in Q4 2022 (a decline of 99.7%).
- Business Quant data shows CYTK's Receivables at $6.83 million (Q1 2026), $17.76 million (Q4 2025) and $1.81 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn | 24.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.43 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 8.41 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 16.65 Mn |
| Sep 30, 2024 | 244,000.00 |
| Mar 31, 2024 | 834,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 985,000.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 6.06 Mn |
| Dec 31, 2021 | 51.82 Mn |
| Sep 30, 2021 | 644,000.00 |
| Jun 30, 2021 | 2.70 Mn |
API Access
Cytokinetics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();